SI
Sofinnova Investments Portfolio holdings
AUM
$2.32B
1-Year Est. Return
101.65%
This Fund
S&P 500
1 Year Est. Return
+101.65%
AUM
$2.32B
AUM Growth
+$689M
(+42%)
Holding
70
Top Buys
| 1 | +$72.8M | |
| 2 | +$70.9M | |
| 3 | +$59M | |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
+$56.9M |
| 5 |
AbbVie
ABBV
|
+$38M |
Top Sells
| 1 | +$139M | |
| 2 | +$55.6M | |
| 3 | +$53.2M | |
| 4 |
Roivant Sciences
ROIV
|
+$47.6M |
| 5 |
DexCom
DXCM
|
+$26M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIOA
26
BioAge Labs
BIOA
$830M
| $30.3M | 1.31% |
2,293,788
|
|
||
27
Celcuity
CELC
$5.13B
| $29.9M | 1.29% |
299,417
+46,042
|
|
||
28
Rhythm Pharmaceuticals
RYTM
$6.22B
| $29.1M | 1.25% |
271,394
+24,428
|
|
||
|
CNTA
29
Centessa Pharmaceuticals
CNTA
$4.02B
| $27.6M | 1.19% |
+1,104,274
|
|
||
30
Supernus Pharmaceuticals
SUPN
$2.91B
| $27.5M | 1.19% |
553,095
+176,029
|
|
||
31
Insmed
INSM
$30.1B
| $27.3M | 1.18% |
156,801
+52,462
|
|
||
32
Alcon
ALC
$38.3B
| $26.2M | 1.13% |
+332,520
|
|
||
33
Arcus Biosciences
RCUS
$2.85B
| $26.1M | 1.13% |
1,096,705
-125,558
|
|
||
|
34
DexCom
DXCM
$25.1B
| $25.1M | 1.08% |
378,219
-401,397
|
|
||
35
Pharvaris
PHVS
$1.71B
| $20.7M | 0.89% |
745,169
+5,293
|
|
||
36
Nektar Therapeutics
NKTR
$1.97B
| $18.5M | 0.8% |
438,630
+320,211
|
|
||
37
Compass Therapeutics
CMPX
$923M
| $18.1M | 0.78% |
3,365,446
+1,336,560
|
|
||
|
38
Roivant Sciences
ROIV
$20.4B
| $15.9M | 0.69% |
734,582
-2,414,688
|
|
||
39
AnaptysBio
ANAB
$1.83B
| $13.9M | 0.6% |
287,690
+33,422
|
|
||
40
GE HealthCare
GEHC
$32.1B
| $13.2M | 0.57% |
160,876
+9,791
|
|
||
41
Edgewise Therapeutics
EWTX
$3.21B
| $10.9M | 0.47% |
437,819
-82,421
|
|
||
42
Exact Sciences
EXAS
$19.7B
| $10.3M | 0.44% |
101,443
-263,557
|
|
||
43
Disc Medicine
IRON
$2.28B
| $8.82M | 0.38% |
111,010
+97,457
|
|
||
44
Amylyx Pharmaceuticals
AMLX
$1.58B
| $6.37M | 0.27% |
+527,099
|
|
||
45
Masimo
MASI
$9.16B
| $6.01M | 0.26% |
+46,201
|
|
||
46
uniQure
QURE
$1.06B
| $4.22M | 0.18% |
176,513
+39,651
|
|
||
47
NextCure
NXTC
$47.4M
| $3.16M | 0.14% |
222,654
|
|
||
48
Wave Life Sciences
WVE
$2.51B
| $2.69M | 0.12% |
158,182
-12,761
|
|
||
49
Xenon Pharmaceuticals
XENE
$4.82B
| $2.68M | 0.12% |
+59,900
|
|
||
|
EVMN
50
Evommune Inc
EVMN
$724M
| $2.62M | 0.11% |
+153,320
|
|